Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Fukumasu, Heidge ^a   Rochetti, Arina L ^a   Pires, Pedro R L ^a   Silva, Edson R ^a   Mesquita, Ligia G ^a   Strefezzi, Ricardo F ^a   De Carvalho, Daniel D ^b,c   Dagli, Maria L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b University Health Network   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS(3,5 DICHLORO 2 PYRIDYLOXY)BENZENE; ANDROST 5 EN 3BETA OL; CITCO; CONSTITUTIVE ANDROSTANE RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR AGONIST; HORMONE RECEPTOR STIMULATING AGENT; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PACLITAXEL; TCPOBOP; UNCLASSIFIED DRUG; WT1 PROTEIN; 1,4-BIS(2-(3,5-DICHLOROPYRIDYLOXY))BENZENE; 6-(4-CHLOROPHENYL)IMIDAZO(2,1-B)(1,3)THIAZOLE-5-CARBALDEHYDE O-(3,4-DICHLOROBENZYL)OXIME; ANDROSTANE DERIVATIVE; ANTINEOPLASTIC AGENT; CELL RECEPTOR; DNA METHYLTRANSFERASE; OXIME; PYRIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER CELL LINE; LUNG NON SMALL CELL CANCER; MGMT GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; OVERALL SURVIVAL; TUMOR SUPPRESSOR GENE; WT1 GENE; AGONISTS; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; TUMOR CELL LINE;

ANDROSTENOLS; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DNA MODIFICATION METHYLASES; DRUG SYNERGISM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; OXIMES; PACLITAXEL; PYRIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; WT1 PROTEINS;

EID: 84903552395     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099484     Document Type: Article

References (44)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30. Available: http://www.ncbi.nlm.nih.gov/pubmed/23335087. Accessed 19 September 2013.
2. Berhoune M, Banu E, Scotte F, Prognon P, Oudard S, et al. (2008) Therapeutic strategy for treatment of metastatic non-small cell lung cancer. Ann Pharmacother 42: 1640-1652.Available: http://www.ncbi.nlm.nih.gov/pubmed/ 18957625. Accessed 28 March 2014.
3. Chu Q, Vincent M, Logan D, Mackay JA, Evans WK (2005) Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline. Lung Cancer 50: 355-374.Available: http://www.ncbi.nlm. nih.gov/pubmed/16139391. Accessed 28 March 2014.
4. Kreso A, O'Brien CA, van Galen P, Gan OI, Notta F, et al. (2013) Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 339: 543-548. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 23239622. Accessed 20 March 2014.
5. Cancer multidrug resistance. (2000). Nat Biotechnol 18 Suppl: IT18-20. Available: http://www.ncbi.nlm.nih.gov/pubmed/11221708. Accessed 28 March 2014.
6. Chen Y, Tang Y, Guo C, Wang J, Boral D, et al. (2012) Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. Biochem Pharmacol 83: 1112-1126. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3339266&tool= pmcentrez&rendertype=abstract. Accessed 27 September 2013.
7. Harmsen S, Meijerman I, Febus CL, Maas-Bakker RF, Beijnen JH, et al. (2010) PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line. Cancer Chemother Pharmacol 66: 765-771. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2904455&tool=pmcentrez&rendertype=abstract. Accessed 28 March 2014.
8. Scripture CD, Figg WD (2006) Drug interactions in cancer therapy. Nat Rev Cancer 6: 546-558. Available: http://www.ncbi.nlm.nih.gov/pubmed/16794637. Accessed 28 March 2014.
9. Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, et al. (1998) Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci U S A 95: 12208-12213. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22810&tool= pmcentrez&rendertype=abstract. Accessed 28 March 2014.
10. Goodwin B, Hodgson E, D'Costa DJ, Robertson GR, Liddle C (2002) Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol Pharmacol 62: 359-365. Available: http://www.ncbi.nlm. nih.gov/pubmed/12130689. Accessed 28 March 2014.
11. Willson TM, Kliewer SA (2002) PXR, CAR and drug metabolism. Nat Rev Drug Discov 1: 259-266. Available: http://www.ncbi.nlm.nih.gov/pubmed/12120277.
12. Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, et al. (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275: 15122-15127. Available: http://www.ncbi.nlm.nih.gov/pubmed/10748001. Accessed 28 March 2014.
13. Moreau A, Vilarem MJ, Maurel P, Pascussi JM (n.d.) Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. Mol Pharm 5: 35-41. Available: http://www.ncbi.nlm.nih. gov/pubmed/18159929. Accessed 28 March 2014.
14. Wada T, Gao J, Xie W (2009) PXR and CAR in energy metabolism. Trends Endocrinol Metab 20: 273-279. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 19595610.
15. Pondugula SR, Mani S (2013) Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response. Cancer Lett 328: 1-9. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3518034&tool= pmcentrez&rendertype=abstract. Accessed 22 September 2013.
16. Qiao E, Ji M, Wu J, Ma R, Zhang X, et al. (2013) Expression of the PXR gene in various types of cancer and drug resistance. Oncol Lett 5: 1093-1100. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3628904&tool=pmcentrez&rendertype=abstract. Accessed 4 October 2013.
17. Takizawa D, Kakizaki S, Horiguchi N, Yamazaki Y, Tojima H, et al. (2011) Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis. Carcinogenesis 32: 576-583. Available: http://www.ncbi.nlm.nih.gov/pubmed/21173431. Accessed 28 March 2014.
18. Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, Maronpot RR (2004) The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 64: 7197-7200. Available: http://www.ncbi.nlm.nih.gov/pubmed/15492232. Accessed 4 October 2013.
19. Chakraborty S, Kanakasabai S, Bright JJ (2011) Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells. Br J Cancer 104: 448-459. Available: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3049563&tool=pmcentrez&rendertype=abstract. Accessed 4 October 2013.
20. Wang D, Li L, Yang H, Ferguson SS, Baer MR, et al. (2013) The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies. Blood 121: 329-338. Available: http://www.ncbi.nlm.nih.gov/pubmed/23160467. Accessed 4 October 2013.
21. Sithanandam G, Smith GT, Fields JR, Fornwald LW, Anderson LM (2005) Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: ErbB3 versus Gab1. Am J Respir Cell Mol Biol 33: 490-499. Available: http://www.pubmedcentral.nih.gov/articlerender. fcgi?artid=2715357&tool=pmcentrez&rendertype=abstract. Accessed 28 March 2014.
22. Shiao Y-H, Lupascu ST, Gu YD, Kasprzak W, Hwang CJ, et al. (2009) An intergenic non-coding rRNA correlated with expression of the rRNA and frequency of an rRNA single nucleotide polymorphism in lung cancer cells. PLoS One 4: e7505. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2759515&tool=pmcentrez&rendertype=abstract. Accessed 28 March 2014.
23. Malkinson AM, Dwyer-Nield LD, Rice PL, Dinsdale D (1997) Mouse lung epithelial cell lines - tools for the study of differentiation and the neoplastic phenotype. Toxicology 123: 53-100. Available: http://www.ncbi.nlm. nih.gov/pubmed/9347924. Accessed 23 October 2013.
24. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386. Available: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=10547847.
25. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403-410. Available: http://www.ncbi.nlm. nih.gov/pubmed/2231712. Accessed 31 January 2013.
26. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. Available: http://www.ncbi.nlm.nih.gov/pubmed/11846609. Accessed 28 January 2013.
27. Shan L, Vincent J, Brunzelle JS, Dussault I, Lin M, et al. (2004) Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism. Mol Cell 16: 907-917. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2727924&tool=pmcentrez&rendertype=abstract. Accessed 28 March 2014.
28. Suino K, Peng L, Reynolds R, Li Y, Cha J-Y, et al. (2004) The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization. Mol Cell 16: 893-905. Available: http://www.ncbi.nlm.nih. gov/pubmed/15610733. Accessed 28 March 2014.
29. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612. Available: http://www.ncbi.nlm.nih.gov/ pubmed/15264254. Accessed 20 March 2014.
30. Richards FM (1977) Areas, volumes, packing and protein structure. Annu Rev Biophys Bioeng 6: 151-176. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 326146. Accessed 28 March 2014.
31. Kuntz ID, Blaney JM, Oatley SJ, Langridge R, Ferrin TE (1982) A geometric approach to macromolecule-ligand interactions. J Mol Biol 161: 269-288. Available: http://www.ncbi.nlm.nih.gov/pubmed/7154081. Accessed 28 March 2014.
32. Moustakas DT, Lang PT, Pegg S, Pettersen E, Kuntz ID, et al. (n.d.) Development and validation of a modular, extensible docking program: DOCK 5. J Comput Aided Mol Des 20: 601-619. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 17149653. Accessed 28 March 2014.
33. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, et al. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6: pl1. Available: http://stke.sciencemag.org/cgi/ content/full/sigtrans;6/269/pl1?ijkey=o1bU9IeWNst8.&keytype=ref&siteid= sigtrans. Accessed 19 March 2014.
34. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, et al. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2: 401-404. Available: http://cancerdiscovery. aacrjournals.org/content/2/5/401.full. Accessed 19 March 2014.
35. Thomas CR, Williams TE, Turrisi AT (1998) Don't be mis-guided when the data are silent and the editorial misses the mark. J Clin Oncol 16: 1631-1632. Available: http://www.ncbi.nlm.nih.gov/pubmed/9552078. Accessed 28 March 2014.
36. Huang W, Zhang J, Washington M, Liu J, Parant JM, et al. (2005) Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol 19: 1646-1653. Available: http://www.ncbi.nlm.nih.gov/pubmed/15831521.
37. Fukumasu H, Avanzo JL, Sanches DS, Mennecier G, Mori CMC, et al. (2013) Higher susceptibility of spontaneous and NNK-induced lung neoplasms in connexin 43 deficient CD1 x AJ F1 mice: paradoxical expression of connexin 43 during lung carcinogenesis. Mol Carcinog 52: 497-506. Available: http://www.ncbi.nlm.nih. gov/pubmed/22344786. Accessed 4 October 2013.
38. Mennecier G, Torres LN, Cogliati B, Sanches DS, Mori CM, et al. (2012) Chronic exposure of lung alveolar epithelial type II cells to tobacco-specific carcinogen nnk results in malignant transformation: A new in vitro lung carcinogenesis model. Mol Carcinog. Available: http://www.ncbi.nlm.nih.gov/ pubmed/23203541. Accessed 23 October 2013.
39. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, et al. (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343: 1350-1354. Available: http://www.ncbi.nlm.nih.gov/pubmed/11070098. Accessed 28 March 2014.
40. 6-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer. Genet Test Mol Biomarkers 15: 357-360. Available: http://www.ncbi.nlm.nih.gov/pubmed/21288129 Accessed 28 March 2014.
41. Gu C, Lu J, Cui T, Lu C, Shi H, et al. (2013) Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis. PLoS One 8: e72633. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3784462&tool=pmcentrez&rendertype=abstract. Accessed 7 April 2014.
42. Hayashi S, Oji Y, Kanai Y, Teramoto T, Kitaichi M, et al. (2012) Low Wilms' tumor gene expression in tumor tissues predicts poor prognosis in patients with non-small-cell lung cancer. Cancer Invest 30: 165-171. Available: http://www.ncbi.nlm.nih.gov/pubmed/22148937. Accessed 28 March 2014.
43. Wu C, Zhu W, Qian J, He S, Wu C, et al. (2013) WT1 promotes invasion of NSCLC via suppression of CDH1. J Thorac Oncol 8: 1163-1169. Available: http://www.ncbi.nlm.nih.gov/pubmed/23945386. Accessed 21 January 2014.
44. Xu C, Wu C, Xia Y, Zhong Z, Liu X, et al. (2013) WT1 promotes cell proliferation in non-small cell lung cancer cell lines through up-regulating cyclin D1 and p-pRb in vitro and in vivo. PLoS One 8: e68837. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3731304&tool= pmcentrez&rendertype=abstract. Accessed 7 April 2014.